FORE US Bio Inc. — Form D/A

FORE US Bio Inc. of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2026-07-14. The offering totals $109.6M, of which $70.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Kim BlackwellRelated PersonPhiladelphia, PA
Michael ByrnesRelated PersonPhiladelphia, PA
Erez ChimovitsRelated PersonNESS ZIONA, L3
Rajeev DadooRelated PersonPhiladelphia, PA
William HinshawRelated PersonPhiladelphia, PA
Chandra LeoRelated PersonPhiladelphia, PA
Giovanni MariggiRelated PersonPhiladelphia, PA
Dieter WeinandRelated PersonPhiladelphia, PA
Kim BlackwellDirectorPhiladelphia, PA
Michael ByrnesDirectorPhiladelphia, PA
Erez ChimovitsDirectorNESS ZIONA, L3
Giovanni MariggiDirectorPhiladelphia, PA
Dieter WeinandDirectorPhiladelphia, PA
William HinshawDirectorPhiladelphia, PA
William HinshawExecutive OfficerPhiladelphia, PA
Matthew FoyDirectorNESS ZIONA, L3
Chandra LeoDirectorPhiladelphia, PA
Michal SilverbergDirectorWatertown, MA
Jeff SacherExecutive OfficerPhiladelphia, PA
Matthew RosDirectorPhiladelphia, PA
Matthew RosExecutive OfficerPhiladelphia, PA
Meenu Chhabra KarsonDirectorPhiladelphia, PA
Roberto De PontiDirectorPhiladelphia, PA

Other filings by this issuer (2)

FiledFormOfferingSold
2025-05-15D$46.0M$37.4M
2023-08-24D$122.6M$62.1M

More